This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Optimizing Epilepsy Therapy: Case Study Involving a 50-Year-Old Woman With Poorly Controlled Seizures

Optimizing Epilepsy Therapy: Case Study Involving a 50-Year-Old Woman With Poorly Controlled Seizures


Expert Perspective

Time to Complete

45 minutes


February 22, 2017


February 22, 2018
Add to Queue

Maximum Credits

0.75 / AMA PRA Category 1 CreditTM

Accredited Provider

Provided by Haymarket Medical Education

Commercial Supporter

Supported by an educational grant from Sun Pharmaceutical Industries Ltd.

Program Description

Epilepsy is associated with a significant disease burden that involves continuing challenges for patients and ongoing management challenges for clinicians. One of the most common neurological disorders, epilepsy can occur at all ages and can have many possible symptom presentations and causes. This clinical consult between a primary care clinician and a neurologist discussing the case of a 50-year-old woman diagnosed with partial-onset epilepsy highlights how to approach some of the management challenges faced by clinicians.

Intended Audience

Neurologists and primary care clinicians (internists, family physicians, general practitioners, nurse practitioners, physician assistants) engaged in the management of epilepsy

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Develop a therapeutic regimen that achieves the goals of therapy to eliminate seizures while minimizing adverse effects, which may include drug-sparing strategies and monotherapy
  • Formulate care plans with a patient-centric approach and more effective patient/caregiver communication in regard to treatment options, pill burden, adherence, improving outcomes, and quality of life (QoL)

Conflict Of Interest Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, HME requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. HME resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational activities.


Joseph I. Sirven, MD
Professor of Neurology
Chairman, Department of Neurology
Mayo Clinic
Scottsdale, AZ

Dr. Sirven has received consulting fees from Acorda Therapeutics, Inc.; NeuroPace, Inc.; UCB, Inc.; and Upsher-Smith Laboratories, Inc.

Paul P. Doghramji, MD
Family Physician
Collegeville Family Practice
Collegeville, PA

Dr. Doghramji has received consulting fees from Allergan, AstraZeneca, Ironwood Pharmaceuticals, and Merck & Co. He is also on the speakers’ bureaus for AstraZeneca, Merck & Co., and Takeda Pharmaceuticals U.S.A., Inc.

Faculty Reviewer
Marcello Morgan, MD, MPH, CHCP

Associate Medical Director
Haymarket Medical Education
Paramus, NJ

Dr. Morgan has nothing to disclose with regard to commercial support.

Accredited Provider Disclosure

Haymarket Medical Education staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Haymarket Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Haymarket Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.


The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Haymarket Medical Education and Sun Pharmaceutical Industries Ltd. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

If you have any questions relating to the accreditation of this activity, please contact


To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

Privacy Policy


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue